Literature DB >> 1958287

Multiple interactions at the natural killer workshop.

K Kärre1, M Hansson, R Kiessling.   

Abstract

The cell surface receptors and their ligands that control natural killer (NK) cell adhesion, homing, cytokine secretion and target cell recognition are beginning to yield their secrets, as 'NKologists' adopt the same 'multiple interaction strategy' as the cells themselves. This report from the recent NK workshop updates progress on these receptors and on the origin, regulation and physiology of the cells.

Mesh:

Substances:

Year:  1991        PMID: 1958287     DOI: 10.1016/0167-5699(91)90062-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  6 in total

Review 1.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

Review 2.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

3.  Natural killer cell activation-associated induction of target cell DNA fragmentation in a spontaneously regressing rat histiocytoma.

Authors:  J J Bright; S Kausalya; A Khar
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

4.  A study of granulated metrial gland cell differentiation in pregnant, macrophage-deficient, osteopetrotic (op/op) mice.

Authors:  Y Kiso; J W Pollard; B A Croy
Journal:  Experientia       Date:  1992-10-15

5.  Peripheral membrane molecules of leukocytes and NK cytotoxicity.

Authors:  J Kubrycht; P Malíková; N H Huan; A Fiserová; K Bezouska; P Kruzík; K Stajner; V Moravec; M Pospísil
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

6.  Thymic origin of embryonic intestinal gamma/delta T cells.

Authors:  D Dunon; M D Cooper; B A Imhof
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.